David Trexler is the Senior Vice President of Oncology at EMD Serono.
In this role, he is responsible for leading the strategic commercial direction of the U.S. oncology franchise, while collaborating as a leader in the strategic alliance between Merck KGaA, Darmstadt, Germany and Pfizer to accelerate the two companies' immuno-oncology portfolios.
With nearly 30 years of pharmaceutical marketing, sales, alliance management and business development experience, David brings an accomplished track record of business success to the company.
Prior to joining EMD Serono, David spent a decade at Eisai, where he most recently served as Senior Vice President, Oncology Business Unit in the Americas. As an executive member of both the U.S. management team and global oncology business unit, he was responsible for the company's oncology portfolio in the U.S., Canada and Latin America. Earlier in his career, David served as a senior marketing director at Mylan Bertek Pharmaceuticals and spent nearly 20 years at Sanofi-Aventis in various marketing and sales roles of increasing responsibility.
David's past Board memberships include the Health Institute of New Jersey, Sister's Network, Inc. - a National African American Breast Cancer Survivorship Organization and the Visiting Nurse Association of Northern New Jersey.
David holds a BS in Biology from Lenoir-Rhyne University and an MBA from Fairleigh Dickinson University.